Back to search
Moderate to Severe Chronic Plaque Psoriasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Chronic Plaque Psoriasis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate to Severe Chronic Plaque Psoriasis trials you may qualify forThe goal of this trial is to assess whether the efficacy of CMAB015 is similar to that of Secukinumab in patients with moderate-severe chronic plaque psoriasis.…
The purpose of the study is to evaluate the pharmacokinetic (PK) of certolizumab pegol (CZP) in study participants aged 6 to 17 years with moderate to severe ch…